Location: SAN FRANCISCO, CA
CIK: 0001776382 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 15, 2026
Total Value: $281M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALXO | ALX ONCOLOGY HLDGS INC | 12,884,638 (+32.8%) | $25.83M (+135.7%) | 9.2% | — | — | COM | 00166B105 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALMS | ALUMIS INC | 4,528,408 (-2.0%) | $99.76M (+121.3%) | 35.6% | — | — | COM | 022307102 |
| ARTV | ARTIVA BIOTHERAPEUTICS INC | 531,337 (-18.1%) | $3.422M (+23.0%) | 1.2% | — | — | COM | 04317A107 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 489,194 | $13.7M | 4.9% | — | — | COM | 413197104 |
| LYEL | LYELL IMMUNOPHARMA INC | 337,697 | $6.774M | 2.4% | — | — | COM | 55083R203 |
| PHVS | PHARVARIS N V | 4,639,304 | $131M | 46.7% | — | — | COM | N69605108 |